These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31537303)

  • 1. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
    Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
    Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection strategies for neuroendocrine pancreatic neoplasms.
    Watzka FM; Laumen C; Fottner C; Weber MM; Schad A; Lang H; Musholt TJ
    Langenbecks Arch Surg; 2013 Mar; 398(3):431-40. PubMed ID: 23143147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.
    Sharpe SM; In H; Winchester DJ; Talamonti MS; Baker MS
    J Gastrointest Surg; 2015 Jan; 19(1):117-23; discussion 123. PubMed ID: 25155459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
    Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
    Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small pancreatic neuroendocrine tumors: Resect or enucleate?
    Beane JD; Borrebach JD; Billderback A; Onuma AE; Adam MA; Zureikat AH; Pitt HA
    Am J Surg; 2021 Jul; 222(1):29-34. PubMed ID: 33317810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
    Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
    World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ye H; Xu HL; Shen Q; Zheng Q; Chen P
    J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
    J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
    Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
    Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.
    Haynes AB; Deshpande V; Ingkakul T; Vagefi PA; Szymonifka J; Thayer SP; Ferrone CR; Wargo JA; Warshaw AL; Fernández-del Castillo C
    Arch Surg; 2011 May; 146(5):534-8. PubMed ID: 21576607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
    Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
    Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors.
    Chawla A; Williams RT; Sich N; Clancy T; Wang J; Ashley S; Pezzi C; Swanson R
    J Surg Oncol; 2018 Nov; 118(6):983-990. PubMed ID: 30212595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
    Cloyd JM; Kopecky KE; Norton JA; Kunz PL; Fisher GA; Visser BC; Dua MM; Park WG; Poultsides GA
    Surgery; 2016 Sep; 160(3):708-13. PubMed ID: 27216830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
    Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
    Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
    Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.